Generic placeholder image

Current Hypertension Reviews

Editor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

Preface

2023 Challenges for the Management of Hypertension

Author(s): Kazuomi Kario

Volume 19, Issue 1, 2023

Published on: 09 March, 2023

Page: [1 - 3] Pages: 3

DOI: 10.2174/157340211901230309162453

Next »
[1]
Kario K. Diversity in Hypertension and Cardiovascular Disease Around the Globe. Curr Hypertens Rev 2021; 17: 1-2.
[2]
Itoh H, Miyashita K. Invitation to the 29th scientific meeting of the International Society of Hypertension: ISH2022 Kyoto. Hypertens Res 2022; 45: 186-7.
[3]
Tomaszewski M, Itoh H. ISH2022KYOTO Hypertension Zero Declaration. Hypertens Res 2023; 46: 1-2.
[4]
Kario K, Chia YC, Siddique S, et al. Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network. J Clin Hypertens 2022; 24: 213-23.
[5]
Neal B, Wu Y, Feng X, et al. Effect of Salt Substitution on Cardiovascular Events and Death. N Engl J Med 2021; 385: 1067-77.
[6]
Kario K. Nocturnal Hypertension: New Technology and Evidence. Hypertension 2018; 71: 997-1009.
[7]
Kario K, Williams B. Nocturnal hypertension and heart failure: Mechanisms, evidence, and new treatments. Hypertension 2021; 78: 564-77.
[8]
Kario K, Hettrick DA, Prejbisz A, Januszewicz A. Obstructive Sleep Apnea-Induced Neurogenic Nocturnal Hypertension: A Potential Role of Renal Denervation? Hypertension 2021; 77: 1047-60.
[9]
Hoshide S, Kanegae H, Kario K. Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events. Hypertens Res 2021; 44: 1138-46.
[10]
Kario K, Hoshide S, Mizuno H, et al. on behalf of JAMP study group. Nighttime blood pressure phenotype and cardiovascular prognosis: The practitioner-based nationwide JAMP Study. Circulation 2020; 142: 1810-20.
[11]
Fujiwara T, Hoshide S, Kanegae H, Kario K. Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study. Hypertension 2020; 76: 259-66.
[12]
Kario K, Shin J, Chen CH, et al. Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia Network. J Clin Hypertens 2019; 21: 1250-83.
[13]
Kario K, Tomitani N, Iwashita C, Shiga T, Kanegae H. Simultaneous self-monitoring comparison of a supine algorithm-equipped wrist nocturnal home blood pressure monitoring device with an upper arm device. J Clin Hypertens 2021; 23: 793-801.
[14]
Tomitani N, Hoshide S, Kario K. Accurate nighttime blood pressure monitoring with less sleep disturbance. Hypertens Res 2021; 44: 1671-3.
[15]
Kario K. Essential manual of perfect 24-hour blood pressure management from morning to nocturnal hypertension. (2nd ed.). London: Wiley 2022; pp. 1-374.
[16]
Jordan J, Biaggioni I, Kotsis V, et al. Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese Society of Hypertension. Hypertens Res 2023; 46: 291-4.
[17]
Kario K, Hoshide S, Mogi M. Uncontrolled hypertension: the greatest challenge and perspectives in Asia. Hypertens Res 2022; 45: 1847-9.
[18]
Kario K, Tomitani N, Nishizawa M, Harada N, Kanegae H, Hoshide S. Concept, study design, and baseline blood pressure control status of the nationwide prospective HI-JAMP study using multisensor ABPM. Hypertens Res 2023; 46: 357-67.
[19]
Tomitani N, Hoshide S, Kario K. HI-JAMP study investigators. Diagnostic agreement of masked uncontrolled hypertension detected by ambulatory blood pressure and home blood pressure measured by an all-in-one BP monitoring device: The HI-JAMP study. Hypertens Res 2023; 46: 157-64.
[20]
Kario K, Hoshide S, Tomitani N, et al. HI–JAMP Study Group. Inconsistent control status of office, home, and ambulatory blood pressure all taken using the same device: The HI-JAMP study baseline data. Am J Hypertens 2023; 36: 90-101.
[21]
Kario K, Hasebe N, Okumura K, et al. Home Blood Pressure Can Predict the Risk for Stroke/Bleeding Events in Elderly Patients With Nonvalvular Atrial Fibrillation From the ANAFIE Registry. Hypertension 2022; 79: 2696-705.
[22]
Ikeda S, Shinohara K, Enzan N, et al. A higher resting heart rate is associated with cardiovascular event risk in patients with type 2 diabetes mellitus without known cardiovascular disease. Hypertens Res 2023 Jan 27; Online ahead of print
[http://dx.doi.org/10.1038/s41440-023-01178-1] [PMID: 36707715]
[23]
Oba Y, Kabutoya T, Kohro T, et al. Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition System. Circ J 2023; 87: 336-44. Epub 2022 Oct 7.
[http://dx.doi.org/10.1253/circj.CJ-22-0314] [PMID: 36216562]
[24]
Tomitani N, Hoshide S, Buranakitjaroen P, et al. HOPE Asia Network. Regional differences in office and self-measured home heart rates in Asian hypertensive patients: AsiaBP@Home study. J Clin Hypertens 2021; 23: 606-13.
[25]
Kario K, Hoshide S, Mogi M. Lifetime home BP-centered approach is the core from onset to aggravation of hypertension. Hypertens Res 2023 Jan 31; Online ahead of print
[http://dx.doi.org/10.1038/s41440-023-01174-5] [PMID: 36721005]
[26]
Kario K, Shimbo D, Hoshide S, et al. The emergence of home blood pressure-guided management of hypertension based on global evidence. Hypertension 2019; 74: 229-36.

© 2024 Bentham Science Publishers | Privacy Policy